Specific combinations of donor and recipient KIR-HLA genotypes predict for large differences in outcome after cord blood transplantation
Takuya Sekine(Karolinska Institutet), Katayoun Rezvani(The University of Texas MD Anderson Cancer Center), Gabriela Rondón(The University of Texas MD Anderson Cancer Center), Muharrem Müftüoğlu(The University of Texas MD Anderson Cancer Center), Darius Armstrong‐James(Imperial College London), Simrit Parmar(The University of Texas MD Anderson Cancer Center), Yago Nieto(The University of Texas MD Anderson Cancer Center), Rafet Başar(The University of Texas MD Anderson Cancer Center), Amin M. Alousi(McGill University), David Marín(Hammersmith Hospital), Anushruti Sarvaria(The University of Texas MD Anderson Cancer Center), Jeffrey J. Molldrem(The University of Texas MD Anderson Cancer Center), Richard E. Champlin(The University of Texas MD Anderson Cancer Center), Chitra Hosing(The University of Texas MD Anderson Cancer Center), Pramod P. Mehta(The University of Texas MD Anderson Cancer Center), Nina Shah(The University of Texas MD Anderson Cancer Center), Hila Shaim(The University of Texas MD Anderson Cancer Center), Elizabeth J. Shpall(Scripps MD Anderson Cancer Center), Uday Popat(The University of Texas MD Anderson Cancer Center), Amanda Olson(The University of Texas MD Anderson Cancer Center), Partow Kebriaei(The University of Texas MD Anderson Cancer Center), Catherine Sobieski(The University of Texas MD Anderson Cancer Center), Nobuhiko Imahashi(The University of Texas MD Anderson Cancer Center), Betül Oran(The University of Texas MD Anderson Cancer Center), Li Li(The University of Texas MD Anderson Cancer Center), Kai Cao(Beijing Tongren Hospital), Enli Liu(The University of Texas MD Anderson Cancer Center), Abdullah Alsuliman(The University of Texas MD Anderson Cancer Center), Roy B. Jones(The University of Texas MD Anderson Cancer Center), Börje S. Andersson(The University of Texas MD Anderson Cancer Center), Kayo Kondo(The University of Texas MD Anderson Cancer Center), Silke Paust(Scripps Research Institute)
Cited by 62
Related Papers
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
|Journal of Clinical Oncology|1997|1.3k